The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

Bos, Isabelle; Vos, Stephanie; Vandenberghe, Rik; Scheltens, Philip; Engelborghs, Sebastiaan; Frisoni, Giovanni; Molinuevo, José Luis; Wallin, Anders; Lleó, Alberto; Popp, Julius; Martinez-Lage, Pablo; Baird, Alison; Dobson, Richard; Legido-Quigley, Cristina; Sleegers, Kristel; Van Broeckhoven, Christine; Bertram, Lars; Ten Kate, Mara; Barkhof, Frederik; Zetterberg, Henrik; Lovestone, Simon; Streffer, Johannes; Visser, Pieter Jelle

doi:10.1186/s13195-018-0396-5

Advanced search

Browse by...

Deposit

Highlights

More informations

Title		The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
Authors		Bos, Isabelle Vos, Stephanie Vandenberghe, Rik Scheltens, Philip Engelborghs, Sebastiaan Frisoni, Giovanni Molinuevo, José Luis Wallin, Anders Lleó, Alberto Popp, Julius Martinez-Lage, Pablo Baird, Alison Dobson, Richard Legido-Quigley, Cristina Sleegers, Kristel Van Broeckhoven, Christine Bertram, Lars Ten Kate, Mara Barkhof, Frederik Zetterberg, Henrik Lovestone, Simon Streffer, Johannes Visser, Pieter Jelle show all authors [1 - 23]
Published in		Alzheimer's research & therapy. 2018, vol. 10, no. 1, 64
Abstract		There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer's disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery (EMIF-AD MBD) study. In this report we describe the design of the study, the methods used and the characteristics of the participants.
Identifiers		DOI: 10.1186/s13195-018-0396-5 PMID: 29980228
Full text		Article (Published version) (747 Kb) - Limited access to UNIGE
Structures		Faculté de médecine / Section de médecine clinique / Département de psychiatrie
Research groups		Neuropsychiatrie et Biomarqueurs de la maladie d'Alzheimer (991) Troubles de mémoire et maladie d'Alzeimer (935)
Citation (ISO format)		BOS, Isabelle et al. The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics. In: Alzheimer's Research and Therapy, 2018, vol. 10, n° 1, p. 64. doi: 10.1186/s13195-018-0396-5 https://archive-ouverte.unige.ch/unige:115255